Literature DB >> 22480199

Commercial Carlinae radix herbal drug: botanical identity, chemical composition and antimicrobial properties.

Zorica Stojanović-Radić1, Ljiljana Čomić, Niko Radulović, Polina Blagojević, Tatjana Mihajilov-Krstev, Jelena Rajković.   

Abstract

CONTEXT: Carlinae radix is an herbal drug, commonly used by the locals in southeastern Serbia for the treatment of respiratory and urogenital diseases and, externally, for various skin conditions. There still seems to be no detailed studies correlating the chemical composition of this drug and its ethnopharmacological uses.
OBJECTIVE: Chemical composition, antimicrobial activity and mode of action of C. radix essential oil, isolated from commercial samples (confirmation of whose true biological identity was also the aim of this work) were analyzed. Antimicrobial potential of decoctions (extracts prepared by boiling plant material in a given solvent), used in ethnomedicine preferentially to the pure essential oil, was also investigated.
MATERIALS AND METHODS: The essential oil obtained by hydrodistillation was screened for antimicrobial activity by disc diffusion and broth microdilution methods. Effects of the oil on the growth of Staphylococcus aureus cells were investigated using turbidimetric measurements and visualized using scanning electron microscopy. Analyses of the chemical composition of the oils were done using gas chromatography and gas chromatography/mass spectrometry. RESULTS AND DISCUSSION: Both the essential oil and the decocts exhibited a very high antimicrobial activity against all tested strains, with S. aureus as the most sensitive one [e.g., for the oil sample the values for minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were 0.02, 0.04 µL/mL, respectively]. Growth curves of S. aureus demonstrated a significant decrease in turbidity (for the MIC concentration this amounted to ca. 70%) showing a concentration-dependent lysis of the cells, confirmed by scanning electron microscopy. Chemical composition, anatomical and morphological features of the sample pointed to Carlina acanthifolia L. (Asteraceae) instead of Carlina acaulis L. (Asteraceae).
CONCLUSION: The results showed significant antimicrobial effect of the essential oil and the decoctions and support the use of this plant in ethnomedicine for the treatment of various human infections, especially those caused by S. aureus. Adulteration of the drug would not cause significant differences in its biological activity, since chemical composition of the sample showed high similarity with those containing C. acaulis roots.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480199     DOI: 10.3109/13880209.2011.649214

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  4 in total

Review 1.  Back to the Roots-An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils.

Authors:  Karin Lunz; Iris Stappen
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

2.  In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka.

Authors:  Maciej Strzemski; Kamil Wojnicki; Ireneusz Sowa; Kamila Wojas-Krawczyk; Paweł Krawczyk; Ryszard Kocjan; Justyna Such; Michał Latalski; Artur Wnorowski; Magdalena Wójciak-Kosior
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

3.  Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.

Authors:  P Skopiński; B J Bałan; J Kocik; R Zdanowski; S Lewicki; M Niemcewicz; K Gawrychowski; E Skopińska-Różewska; W Stankiewicz
Journal:  Mediators Inflamm       Date:  2013-06-27       Impact factor: 4.711

4.  Comprehensive Evaluation of the Antibacterial and Antifungal Activities of Carlina acaulis L. Essential Oil and Its Nanoemulsion.

Authors:  Antonio Rosato; Alexia Barbarossa; Ahmed M Mustafa; Giulia Bonacucina; Diego Romano Perinelli; Riccardo Petrelli; Filippo Maggi; Eleonora Spinozzi
Journal:  Antibiotics (Basel)       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.